-
COST-EFFECTIVENESS OF A LOW-THRESHOLD MOBILE MEDICAL UNIT PROVIDING OPIOID USE DISORDER CARE IN AN URBAN SETTING
Mar 18, 2026, 21:38 PM -
100% WHEY PEPTIDE-BASED FORMULAS COMPARED TO POLYMERIC ENTERAL NUTRITION AMONG CHILDREN RECEIVING HOME ENTERAL NUTRITION: A COST-BENEFIT ANALYSIS
Mar 18, 2026, 21:38 PM -
DECODING THE PREDICTIVE ROLE OF COMPLETE RESPONSE/REMISSION RATE (CR) FOR OVERALL SURVIVAL (OS) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Mar 18, 2026, 21:38 PM -
ANALYSIS OF THE EXPENDITURE OF PHARMACEUTICALS PRESCRIBED FOR THE INDICATION OF FEMALE INFERTILITY IN HUNGARY FOR THE PERIOD 2015-2023
Mar 18, 2026, 21:38 PM -
CHARACTERISTICS, TREATMENT PATTERNS, AND OUTCOMES OF PATIENTS WITH NON-SMALL CELL LUNG CANCER ACROSS CLINICO-GENOMIC DATABASE AND ELECTRONIC MEDICAL RECORDS
Mar 18, 2026, 21:38 PM -
PSYCHOMETRIC EVALUATION OF SKINDEX-16 AA, THE ALOPECIA AREATA SYMPTOM IMPACT SCALE (AASIS), AND THE SCALP HAIR ASSESSMENT PATIENT-REPORTED OUTCOME (PRO) IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
Mar 18, 2026, 21:38 PM -
COMBINING PLASMA COLLECTION WITH DEMAND DIVERSION TO ACHIEVE IMMUNOGLOBULIN SELF-SUFFICIENCY IN CANADA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF ¹77LU-PSMA-617 VERSUS CABAZITAXEL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: AN ANALYSIS BASED ON REAL-WORLD DATA AND THERAP TRIAL
Mar 18, 2026, 21:38 PM -
GLOBAL PREVALENCE AND CLINICAL PRESENTATION OF ALOPECIA AREATA: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
ILD SEVERITY AND CLINICAL MANAGEMENT IN THE REAL-WORLD SETTING
Mar 18, 2026, 21:38 PM -
EXPLORING LIFE SATISFACTION AS AN OUTCOME OF INTEREST FOR VALUE ASSESSMENT
Mar 18, 2026, 21:38 PM -
MULTI-AGENT GENERATIVE AI TO SIMULATE SPONSOR-HTA INTERACTIONS DURING REIMBURSEMENT PROCESSES: IDENTIFYING EVIDENCE GAPS AND INFORMING MITIGATION STRATEGIES
Mar 18, 2026, 21:38 PM -
REAL-WORLD ENDPOINT MAPPING AND IDENTIFICATION OF EVOLVING PHENOTYPES OF POMPE DISEASE USING MACHINE LEARNING
Mar 18, 2026, 21:38 PM -
RWE FOR SINGLE AND WELL-CONTROLLED STUDIES: AN EVALUATION OF FDA SUBMISSIONS FOR EFFECTIVENESS
Mar 18, 2026, 21:38 PM -
PREVALENCE OF POLYCYSTIC OVARY SYNDROME (PCOS) AND BURDEN OF DISEASE AMONG WOMEN AGES 18-44 IN THE US, NATIONAL HEALTH AND WELLNESS SURVEY
Mar 18, 2026, 21:38 PM -
DETERMINANTS OF HIV STATUS UNAWARENESS AND ANTIRETROVIRAL THERAPY USE AMONG PEOPLE WITH HIV IN ESWATINI
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS AND BUDGET IMPACT OF THE ETONOGESTREL SUBDERMAL CONTRACEPTIVE IMPLANT (ESI) IN BRAZIL
Mar 18, 2026, 21:38 PM -
SYNTHETIC PROGRESSION-FREE SURVIVAL DATA GENERATION FROM PUBLISHED AGGREGATE TRIAL DATA
Mar 18, 2026, 21:38 PM -
ESTIMATION OF FAIRNESS OF DISTRIBUTION OF HUNGARIAN HOSPITAL BEDS BY CALCULATING GINI COEFFICIENT
Mar 18, 2026, 21:38 PM -
POINT-OF-CARE TESTS FOR PEDIATRIC URINARY TRACT INFECTIONS: SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM
